Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Oct;99(1):46-51.
doi: 10.1016/j.ijgo.2007.04.031. Epub 2007 Jun 27.

Clinical indicators for success of misoprostol treatment after early pregnancy failure

C Robledo  1 , J Zhang, J Troendle, K Barnhart, M D Creinin, C Westhoff, X Huang, M Frederick
Affiliations
Randomized Controlled Trial

Clinical indicators for success of misoprostol treatment after early pregnancy failure

C Robledo et al. Int J Gynaecol Obstet. 2007 Oct.

Abstract

Objective: To identify clinical indicators for success of misoprostol treatment after early pregnancy failure.

Methods: A total of 473 women with early pregnancy failure received 800 microg of vaginal misoprostol on treatment day 1. At the follow-up visit on day 3, a second dose was given if expulsion was incomplete. On day 8, vacuum aspiration was offered if expulsion had not occurred. Ultrasonography was used as gold standard for success. A Classification and Regression Tree analysis was undertaken to derive two decision trees for the success of misoprostol treatment on study days 3 and 8.

Results: Heavy bleeding after the first dose and an open cervical os were identified as clinical indicators of treatment success on day 3. Treatment success occurred in 84% of women with either or both indicators. Reporting passage of tissue after a second misoprostol dose and old blood in the vagina were potential indicators of treatment success or failure on day 8. A woman with either of these indicators has a 65% chance of treatment success after the second dose. Conversely, a woman with neither indicator on day 8 has a 94% chance of treatment failure.

Conclusion: Standard clinical findings may be useful as indicators for success or failure of medical management of early pregnancy failure in settings with limited or no access to ultrasonography. More research to identify even better indicators is warranted.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Decision tree obtained from Classification and Regression Tree analysis to predict success of misoprostol treatment on day 3.
Figure 2
Figure 2
Decision tree obtained from Classification and Regression Tree analysis to predict success of misoprostol treatment on day 8.
See this image and copyright information in PMC

References

    1. Alberman E. Spontaneous abortions: epidemiology. In: Stabile I, Grudzinskas G, Chard T, editors. Spontaneous abortion: diagnosis and treatment. London: Springer-Verlag; 1992. pp. 19–20.
    1. Creinin M, Schwartz J, Guido R, Pymar H. Early pregnancy failure – current management concepts. Obstet Gynecol Surv. 2001;56:105–13. - PubMed
    1. Zhang J, Gilles J, Barnhart K, Creinin M, Westhoff C, Frederick M. Comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;358:761–9. - PubMed
    1. Lee D, Cheung L, Haines C, Chan K, Chung T. Comparison of the psychologic impact and client satisfaction of surgical treatment with medical treatment of spontaneous abortion: a randomized controlled trial. Am J Obstet Gynecol. 2001;185:953–8. - PubMed
    1. Graziosi G, Bruinse H, Reuwer P, Mol B. Women’s preferences for misoprostol in case of early pregnancy failure. Eur J Obstet Gynecol Reprod Biol. 2006;124:184–6. - PubMed

Publication types

Substances